299 related articles for article (PubMed ID: 16873579)
1. On the mechanism of action of 9-O-arylalkyloxime derivatives of 6-O-mycaminosyltylonolide, a new class of 16-membered macrolide antibiotics.
Karahalios P; Kalpaxis DL; Fu H; Katz L; Wilson DN; Dinos GP
Mol Pharmacol; 2006 Oct; 70(4):1271-80. PubMed ID: 16873579
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro antibiotic activity of 16-membered 9-O-arylalkyloxime macrolides.
Fu H; Marquez S; Gu X; Katz L; Myles DC
Bioorg Med Chem Lett; 2006 Mar; 16(5):1259-66. PubMed ID: 16343900
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the ribosomal peptidyl transferase reaction by the mycarose moiety of the antibiotics carbomycin, spiramycin and tylosin.
Poulsen SM; Kofoed C; Vester B
J Mol Biol; 2000 Dec; 304(3):471-81. PubMed ID: 11090288
[TBL] [Abstract][Full Text] [Related]
4. Dissecting the ribosomal inhibition mechanism of a new ketolide carrying an alkyl-aryl group at C-13 of its lactone ring.
Krokidis MG; Kostopoulou ON; Kalpaxis DL; Dinos GP
Int J Antimicrob Agents; 2010 Mar; 35(3):235-9. PubMed ID: 20045632
[TBL] [Abstract][Full Text] [Related]
5. Interplay between the ribosomal tunnel, nascent chain, and macrolides influences drug inhibition.
Starosta AL; Karpenko VV; Shishkina AV; Mikolajka A; Sumbatyan NV; Schluenzen F; Korshunova GA; Bogdanov AA; Wilson DN
Chem Biol; 2010 May; 17(5):504-14. PubMed ID: 20534348
[TBL] [Abstract][Full Text] [Related]
6. Conjugates of amino acids and peptides with 5-o-mycaminosyltylonolide and their interaction with the ribosomal exit tunnel.
Shishkina A; Makarov G; Tereshchenkov A; Korshunova G; Sumbatyan N; Golovin A; Svetlov M; Bogdanov A
Bioconjug Chem; 2013 Nov; 24(11):1861-9. PubMed ID: 24090034
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of macrolide action: the josamycin and erythromycin cases.
Lovmar M; Tenson T; Ehrenberg M
J Biol Chem; 2004 Dec; 279(51):53506-15. PubMed ID: 15385552
[TBL] [Abstract][Full Text] [Related]
8. Time-resolved binding of azithromycin to Escherichia coli ribosomes.
Petropoulos AD; Kouvela EC; Starosta AL; Wilson DN; Dinos GP; Kalpaxis DL
J Mol Biol; 2009 Jan; 385(4):1179-92. PubMed ID: 19071138
[TBL] [Abstract][Full Text] [Related]
9. Visualizing the 16-membered ring macrolides tildipirosin and tilmicosin bound to their ribosomal site.
Poehlsgaard J; Andersen NM; Warrass R; Douthwaite S
ACS Chem Biol; 2012 Aug; 7(8):1351-5. PubMed ID: 22563863
[TBL] [Abstract][Full Text] [Related]
10. Cis-acting resistance peptides reveal dual ribosome inhibitory action of the macrolide josamycin.
Lovmar M; Vimberg V; Lukk E; Nilsson K; Tenson T; Ehrenberg M
Biochimie; 2009 Aug; 91(8):989-95. PubMed ID: 19463886
[TBL] [Abstract][Full Text] [Related]
11. The structural basis of macrolide-ribosome binding assessed using mutagenesis of 23S rRNA positions 2058 and 2059.
Pfister P; Jenni S; Poehlsgaard J; Thomas A; Douthwaite S; Ban N; Böttger EC
J Mol Biol; 2004 Oct; 342(5):1569-81. PubMed ID: 15364582
[TBL] [Abstract][Full Text] [Related]
12. Binding site of the bridged macrolides in the Escherichia coli ribosome.
Xiong L; Korkhin Y; Mankin AS
Antimicrob Agents Chemother; 2005 Jan; 49(1):281-8. PubMed ID: 15616307
[TBL] [Abstract][Full Text] [Related]
13. Binding and action of CEM-101, a new fluoroketolide antibiotic that inhibits protein synthesis.
Llano-Sotelo B; Dunkle J; Klepacki D; Zhang W; Fernandes P; Cate JH; Mankin AS
Antimicrob Agents Chemother; 2010 Dec; 54(12):4961-70. PubMed ID: 20855725
[TBL] [Abstract][Full Text] [Related]
14. Stepwise binding of tylosin and erythromycin to Escherichia coli ribosomes, characterized by kinetic and footprinting analysis.
Petropoulos AD; Kouvela EC; Dinos GP; Kalpaxis DL
J Biol Chem; 2008 Feb; 283(8):4756-65. PubMed ID: 18079110
[TBL] [Abstract][Full Text] [Related]
15. Binding site of macrolide antibiotics on the ribosome: new resistance mutation identifies a specific interaction of ketolides with rRNA.
Garza-Ramos G; Xiong L; Zhong P; Mankin A
J Bacteriol; 2001 Dec; 183(23):6898-907. PubMed ID: 11698379
[TBL] [Abstract][Full Text] [Related]
16. Macrolide antibiotics in the ribosome exit tunnel: species-specific binding and action.
Kannan K; Mankin AS
Ann N Y Acad Sci; 2011 Dec; 1241():33-47. PubMed ID: 22191525
[TBL] [Abstract][Full Text] [Related]
17. Macrolide antibiotic interaction and resistance on the bacterial ribosome.
Poehlsgaard J; Douthwaite S
Curr Opin Investig Drugs; 2003 Feb; 4(2):140-8. PubMed ID: 12669373
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antibacterial activity of a novel class of 4'-substituted 16-membered ring macrolides derived from tylosin.
Phan LT; Jian T; Chen Z; Qiu YL; Wang Z; Beach T; Polemeropoulos A; Or YS
J Med Chem; 2004 Jun; 47(12):2965-8. PubMed ID: 15163176
[TBL] [Abstract][Full Text] [Related]
19. Improving on nature: antibiotics that target the ribosome.
Sutcliffe JA
Curr Opin Microbiol; 2005 Oct; 8(5):534-42. PubMed ID: 16111914
[TBL] [Abstract][Full Text] [Related]
20. Kinetic studies on the interaction between a ribosomal complex active in peptide bond formation and the macrolide antibiotics tylosin and erythromycin.
Dinos GP; Kalpaxis DL
Biochemistry; 2000 Sep; 39(38):11621-8. PubMed ID: 10995229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
